CLINICAL_TRIALS
trial_result
· 2022-01-14
Clinical Trial Update: Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA [Phase 3]
Summary
Phase 3 clinical trial evaluating the efficacy and safety of sarilumab in giant cell arteritis was terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Giant Cell Arteritis | Phase 3 | Status: TERMINATED | Results posted: 2022-01-14